{
    "clinical_study": {
        "@rank": "142926", 
        "arm_group": [
            {
                "arm_group_label": "Continuous nebulization", 
                "arm_group_type": "Active Comparator", 
                "description": "Continuous nebulization with AKITA"
            }, 
            {
                "arm_group_label": "Discontinuous nebulization", 
                "arm_group_type": "Experimental", 
                "description": "Discontinuous nebulization with AKITA"
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the continuous and sicontinuous delivery of drug with AKITA."
        }, 
        "brief_title": "Lung Bioavailability With Continuous or Discontinuous Nebulization", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Subjects", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  no lung disease\n\n          -  no allergy\n\n        Exclusion Criteria:\n\n          -  smoker"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "6", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913184", 
            "org_study_id": "AKITA continuous"
        }, 
        "intervention": {
            "arm_group_label": [
                "Continuous nebulization", 
                "Discontinuous nebulization"
            ], 
            "intervention_name": "AKITA", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Brussels", 
                    "country": "Belgium", 
                    "zip": "1200"
                }, 
                "name": "Cliniques universitaires Saint-Luc"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "EFFECT OF DRUG TARGETING NEBULIZATION ON LUNG DELIVERY", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Lung bioavailability by urinary monitoring", 
            "safety_issue": "No", 
            "time_frame": "24h after the nebulization"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913184"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cliniques universitaires Saint-Luc- Universit\u00e9 Catholique de Louvain", 
            "investigator_full_name": "G.Reychler", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Duration of the nebulization", 
            "safety_issue": "No", 
            "time_frame": "After the nebulization"
        }, 
        "source": "Cliniques universitaires Saint-Luc- Universit\u00e9 Catholique de Louvain", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cliniques universitaires Saint-Luc- Universit\u00e9 Catholique de Louvain", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}